At Prime Therapeutics (Prime), we are committed to delivering best-in-class solutions and keeping you informed of pharmacy trends so you can make the best health care decisions. Our clinical experts stay ahead of the trends and continuously monitor the glucagon-like peptide-1 (GLP-1) drug pipeline.

As a resource for clients, Prime has a dedicated GLP-1 resources page that provides an education and insights into GLP-1 drugs, which can help clients implement custom strategies that consider affordability, long-term value and member health outcomes. On this page you’ll find:

• Insights from recent Prime studies and press releases
• Episodes of Prime’s Pharmacy Friends podcast, with GLP-1-focused discussions featuring Prime’s experts
• Access to Prime white papers, publications and more featuring a wide range of GLP-1 content

Explore all this and stay informed on the latest GLP-1 advancements, all in one place!